Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its subsidiary, MindWave Innovations Inc., has entered into a 12-month technology services agreement with Singapore-based AQUAE Holdings Pte. Ltd. to deploy MindWave's MindChain infrastructure as the foundational technology for AQUAEChain, a platform designed for insured ALCI Credits. The news, first reported by TechMediaWire, highlights the growing convergence of blockchain technology and environmental asset management.
Under the agreement, MindWave will design, develop, deploy, and host AQUAEChain, which will manage the issuance, verification, tracking, transfer, and retirement of ALCI Credits. MindWave will also provide ongoing technical support. In return, MindWave will receive contracted software development and technology service fees, along with an allocation equal to 20% of total ALCI Credits issued and outstanding on the AQUAEChain network, calculated quarterly using the MindChain issuance ledger. Following the initial 12-month term, the parties expect to transition to a five-year continuing technology services arrangement, subject to mutual agreement and definitive documentation.
This deal matters because it positions MindWave, a wholly owned subsidiary of Apimeds, at the center of a novel platform that could bring greater transparency and efficiency to environmental asset markets. ALCI Credits, which are insured, are designed to measure, verify, and tokenize ecosystem services into institutional-grade assets. By leveraging blockchain, AQUAEChain aims to provide a secure and auditable record of these credits, potentially increasing trust among investors and participants in climate-related markets.
For Apimeds, a clinical-stage biopharmaceutical company focused on developing non-opioid, biologic-based therapies for pain management, this agreement represents a strategic expansion into enterprise blockchain infrastructure. MindWave's MindChain ecosystem includes four verticals: InsurTech through BlockAssure, which is developing a Bermuda-framework platform applying Bitcoin reserves as regulatory capital to support life and property and casualty underwriting; ClimateTech through AQUAE and the ALCI index; HealthTech through the Apitox development program; and RWA Tech through Nexus Global Partners, bringing institutional real estate on-chain within a compliance-first, insurance-enhanced framework. More information about Apimeds is available at www.ApimedsUS.com, and the full press release can be viewed at https://ibn.fm/eZCn1.
The agreement underscores the increasing institutional interest in blockchain-based solutions for environmental and financial markets. If successful, AQUAEChain could serve as a model for other platforms seeking to tokenize real-world assets with insurance backing. For investors, the deal provides a potential new revenue stream for Apimeds and demonstrates the company's ability to monetize its blockchain technology beyond traditional biopharma. The latest updates on APUS are available in the company's newsroom at https://ibn.fm/APUS.
TechMediaWire, which published the announcement, is part of the Dynamic Brand Portfolio at IBN, a network that includes InvestorWire for wire distribution and editorial syndication to 5,000+ outlets. The platform also offers press release enhancement and social media distribution to amplify corporate announcements. For more details, see the full disclaimer at https://www.TechMediaWire.com/Disclaimer.
